Bosulif (Bosutinib Monohydrate) is a prescription medication used to treat chronic myelogenous leukemia-(CML). Bosutinib belongs to a family of medications called protein tyrosine kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Bosulif is usually given after other treatments have failed.
Canadian Pharmacy King currently offers the brand Bosulif from Canada manufactured by Pfizer. There is no generic available for this medication. Bosulif is available in the strength of 100 mg and 500 mg tablets.
The common side effects of Bosulif may include cough, diarrhea, dizziness, headache, mild rash, nausea, stomach of abdominal pain and vomiting.
Talk to your doctor right away if you have any of the serious side effects such as:
• Dark urine;
• Severe stomach or abdominal pain;
• Signs of kidney problems;
• Swelling hands, ankles or feet;
• Yellowing eyes or skin
This is not a complete list of side effects and others may occur. Please call your doctor if you have any further concerns or questions.
You should not take Bosulif if you are allergic to Bosutinib or if you have any other allergies. Before you start taking this medication, talk to your doctor about your medical history such as a history of liver or kidney disease. This medication may you dizzy. Alcohol and marijuana can make you dizzier. You should not drive, use machinery or do any activity that requires you to be alert. Avoid alcoholic beverages as it may increase the risk of serious liver problems. Inform your doctor if you are using marijuana. You should not have immunizations or vaccinations without the consent of your doctor. Be careful when using sharp objects like razors and nail cutters to lower the chance of getting cut, bruised or injured. Inform your doctor if you are pregnant or plan to become pregnant. If you become pregnant, talk to your doctor right away about the risks and benefits of this medication. It is unknown if this medication passes into breast milk.
Check out our latest Blog Post
Skipping Doses and Delaying Treatment: Will Drug Prices Continue to Rise in 2021?